Issue Date: January 15, 2007
PTC and Pfizer form small-molecule pact
PTC Therapeutics has formed a research collaboration and licensing agreement with Pfizer centered on PTC's gene expression modulation by small molecules (GEMS) technology. Pfizer has paid $10 million to PTC and will purchase a $10 million stake in the biopharma company. The collaboration could include 10 drugs, each of which could earn PTC up to $121 million in milestone payments.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society